AU2001285197A1 - Stavudine polymorphic form 1 process - Google Patents

Stavudine polymorphic form 1 process

Info

Publication number
AU2001285197A1
AU2001285197A1 AU2001285197A AU8519701A AU2001285197A1 AU 2001285197 A1 AU2001285197 A1 AU 2001285197A1 AU 2001285197 A AU2001285197 A AU 2001285197A AU 8519701 A AU8519701 A AU 8519701A AU 2001285197 A1 AU2001285197 A1 AU 2001285197A1
Authority
AU
Australia
Prior art keywords
polymorphic form
stavudine polymorphic
stavudine
polymorphic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001285197A
Inventor
Simon Crawford Bristow
Philip Michael Cocks
Rajesh B. Gandhi
Ronald Harland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of AU2001285197A1 publication Critical patent/AU2001285197A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/06—Separation; Purification
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/54—Improvements relating to the production of bulk chemicals using solvents, e.g. supercritical solvents or ionic liquids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001285197A 2000-09-06 2001-08-22 Stavudine polymorphic form 1 process Abandoned AU2001285197A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US23026100P 2000-09-06 2000-09-06
US60230261 2000-09-06
US23176600P 2000-09-12 2000-09-12
US60231766 2000-09-12
PCT/US2001/026225 WO2002020538A2 (en) 2000-09-06 2001-08-22 Stavudine polymorphic form 1 process

Publications (1)

Publication Number Publication Date
AU2001285197A1 true AU2001285197A1 (en) 2002-03-22

Family

ID=26924063

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001285197A Abandoned AU2001285197A1 (en) 2000-09-06 2001-08-22 Stavudine polymorphic form 1 process

Country Status (3)

Country Link
US (1) US20030225279A1 (en)
AU (1) AU2001285197A1 (en)
WO (1) WO2002020538A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006299305B2 (en) * 2005-10-04 2012-04-12 Ac-Sun Aps Cooling apparatus for air conditioning and heat pumps

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130421A (en) * 1988-03-24 1992-07-14 Bristol-Myers Company Production of 2',3'-dideoxy-2',3'-didehydronucleosides
US6207650B1 (en) * 1989-05-15 2001-03-27 Bristol-Myers Squibb Company Antiviral, highly water soluble, stable, crystalline salts of 2′, 3′-dideoxyinosine, 2′, 3′-dideoxy-2′, 3′-didehydrothymidine and 2′, 3′-dideoxy-2′-fluoroinosine
GB9313642D0 (en) * 1993-07-01 1993-08-18 Glaxo Group Ltd Method and apparatus for the formation of particles
US5539099A (en) * 1993-11-15 1996-07-23 Bristol-Myers Squibb Company Process for large-scale preparation of 2',3'-didehydro-2',3'-dideoxynucleosides
US5672698A (en) * 1993-11-15 1997-09-30 Bristol-Myers Squibb Co. Preparation of 2',3'-didehydro-3'-deoxythymidine from 5-methyluridine
US5608049A (en) * 1995-03-10 1997-03-04 Bristol-Myers Squibb Company Preparation of d4T from 5-methyluridine
US5608048A (en) * 1995-06-05 1997-03-04 Bristol-Myers Squibb Company d4 T polymorphic Form 1 process
US6635753B1 (en) * 1998-09-30 2003-10-21 Brantford Chemicals Inc. Process for the preparation of substantially pure stavudine and related intermediates useful in the preparation thereof

Also Published As

Publication number Publication date
US20030225279A1 (en) 2003-12-04
WO2002020538A3 (en) 2002-05-30
WO2002020538A2 (en) 2002-03-14

Similar Documents

Publication Publication Date Title
AU6106999A (en) Process
AU4048399A (en) Polymorphic clopidogrel hydrogenesulphate form
AU3890299A (en) Cryo-sedimentation process
AU2709900A (en) Process for making 2,3-dihalopropanols
EP1127060B8 (en) Hydroboronation process
AU2001244470A1 (en) Assembly process
AU2001291313A1 (en) Process for making 3-amino-2-chloro-4-methylpyridine
AU2002218440A1 (en) New process
AU2001232158A1 (en) Crystallizing process
AU2001245953A1 (en) Oncogenic osteomalacia-related gene 1
AU2002242348A1 (en) Process for obtaining 3'-epilutein
AU2001267769A1 (en) Process
AU2001285197A1 (en) Stavudine polymorphic form 1 process
AU2757299A (en) Novel process
AU1223600A (en) Process
AU2002221623A1 (en) Gene 4
AU6169100A (en) Novel process
AU1165801A (en) Novel process
AU5550700A (en) Novel process
AU2001234795A1 (en) Process for obtaining 1, 2, 3, 5, 6, 7, 8, 8a-oltahydro-1, 2, 8, 8tetramethylnaphthalen-2-yl!etan-1-one
AU4538099A (en) New process
AU5521800A (en) Novel process
AU5995900A (en) Novel process
IL156176A0 (en) Process for making substituted 8-arylquinolinium benzenesulfonate
AU2001284264A1 (en) Screening method 2